Patient-Reported Quality of Life Outcomes after Moderately Hypofractionated and Normofractionated Proton Therapy for Localized Prostate Cancer

Patient-Reported Quality of Life Outcomes after Moderately Hypofractionated and Normofractionated Proton Therapy for Localized Prostate Cancer

We retrospectively evaluated the three-year patient-reported quality of life (QOL) after moderately hypofractionated proton therapy (MHPT) for localized prostate cancer in comparison with that after normofractionated PT (NFPT) using the Expanded Prostate Cancer Index Composite-50. Patients who recei...

Full description

Bibliographic Details
Main Authors: Koichiro Nakajima, Hiromitsu Iwata, Yukiko Hattori, Kento Nomura, Kensuke Hayashi, Toshiyuki Toshito, Yukihiro Umemoto, Shingo Hashimoto, Hiroyuki Ogino, Yuta Shibamoto
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Cancers
Subjects:
proton therapy
prostate cancer
moderately hypofractionation
quality of life
EPIC-50
Online Access:https://www.mdpi.com/2072-6694/14/3/517

Internet

https://www.mdpi.com/2072-6694/14/3/517

Similar Items